Search Results - Standard Search:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov

PubPharm (460)

1

Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020

in: JAMA | (22.01.2021)

by Crane, M. | Shermock, K. | Omer, S. | +1

2

Racial and Ethnic Health Disparities Related to COVID-19

in: JAMA | (22.01.2021)

by Lopez, L. | Hart, L. | Katz, M.

3

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

in: JAMA | (21.01.2021)

by Shimabukuro, T. | Nair, N.

4

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 : A Randomized Clinical Trial

in: JAMA | (21.01.2021)

by Gottlieb, R. | Nirula, A. | Chen, P. | +24

5

Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19

in: JAMA | (21.01.2021)

by Malani, P. | Golub, R.

6

Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System

in: JAMA | Vol. 325, No. 3 (2021), p. 304-306

by Donnelly, J. | Wang, X. | Iwashyna, T. | +1

7

Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines

in: JAMA | Vol. 325, No. 3 (2021), p. 221-222

by Joffe, S.

8

The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials

in: JAMA | Vol. 325, No. 3 (2021), p. 219-220

by Rid, A. | Lipsitch, M. | Miller, F.

9

COVID-19 Conspiracies and Beyond : How Physicians Can Deal With Patients' Misinformation

in: JAMA | Vol. 325, No. 3 (2021), p. 208-210

by Abbasi, J.

10

Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19 : A Randomized Clinical Trial

in: JAMA | Vol. 325, No. 3 (2021), p. 254-264

by Lopes, R. | Macedo, A. | de Barros E Silva, P. | +32

1
2
3
4
5
6
7
8
9
10
11
Next »
[46]